Bermingham Nessan (CIK 0001377759)

Latest company ownership

Shares held
458,250
Last filed at
Dec 8, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 6, 2017 Dec 8, 2017 Intellia Therapeutics, Inc. CEO Sell 3.8 -336,783 -42.36% ✓ $7M